• LY2886721: Potent Oral BACE Inhibitor for Alzheimer’s Resear

  2026-05-25

  LY2886721 is a nanomolar-potency, furothiazine-based BACE1 inhibitor for Alzheimer’s disease research. It enables controlled amyloid beta reduction in vitro and in vivo, with evidence-supported selectivity and workflow compatibility.

• NEDD4L-Mediated PRMT5 Degradation Suppresses CRC Metastasis

  2026-05-24

  This study reveals that the E3 ubiquitin ligase NEDD4L restricts colorectal cancer (CRC) liver metastasis by targeting PRMT5 for degradation, thereby inhibiting the pro-metastatic AKT/mTOR signaling pathway. The findings identify a previously unrecognized NEDD4L–PRMT5 axis as a potential therapeutic target to prevent CRC dissemination.

• BRD4770 and the G9a Axis: Precision Epigenetic Intervention

  2026-05-23

  Explore how BRD4770, a G9a histone methyltransferase inhibitor, empowers precision epigenetic research in cancer. This article reveals unique mechanistic insights and practical assay guidance that go beyond standard applications.

• Low-Molecular Weight Inhibitors Targeting the Alternative Co

  2026-05-22

  This review highlights the development and mechanistic rationale for low-molecular weight inhibitors of the alternative complement pathway, with a focus on highly selective agents such as Iptacopan (LNP023). The findings provide a foundation for targeted therapeutic strategies in complement-mediated diseases and inform assay design for translational research.

• Caspase-4 Colorimetric Assay Kit: Optimizing Pyroptosis Anal

  2026-05-22

  The Caspase-4 Colorimetric Assay Kit streamlines detection of LEVD-dependent caspase-4 activity, enabling robust, quantitative analysis of inflammation and pyroptosis pathways. This guide bridges cutting-edge organelle-targeting research with practical workflows, troubleshooting, and advanced applications for cell fate studies.

• Diphenyleneiodonium Chloride: Benchmarks in Redox Enzyme Res

  2026-05-21

  Diphenyleneiodonium chloride (DPI) is a validated, research-grade inhibitor of NADH oxidases and nitric oxide synthase, widely used to dissect redox enzyme function and cAMP signaling pathways. DPI’s dual mechanism enables precise modulation in oxidative stress research, with well-documented potency and workflow integration benchmarks.

• Dibutyryl-cAMP, Sodium Salt: Strategic Leverage in Translati

  2026-05-21

  Explore the mechanistic power and translational potential of Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt) in dissecting cAMP signaling. This thought-leadership article blends scientific insight, evidence from Alzheimer’s research, and practical guidance for advanced pathway interrogation, offering researchers a strategic edge in experimental design and disease modeling.

• Angiotensin I: Protocol Enhancements for Renin-Angiotensin R

  2026-05-20

  Unlock advanced renin-angiotensin system research with Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu). This guide details workflow optimizations, troubleshooting strategies, and powerful applications for cardiovascular and neuroendocrine studies, leveraging APExBIO’s rigorously validated reagent.

• 3X (DYKDDDDK) Peptide: Precision Tag for Protein Purificatio

  2026-05-20

  The 3X (DYKDDDDK) Peptide, also known as the 3X FLAG peptide, is a synthetic epitope tag designed for high-sensitivity affinity purification and immunodetection of recombinant proteins. Its hydrophilic, calcium-dependent properties enable robust performance in diverse workflows. This article details its molecular rationale, validated applications, and protocol parameters, referencing both peer-reviewed research and APExBIO’s product documentation.

• EGCG Nanoparticle Radiosensitization Enhances FLASH-RT Effic

  2026-05-19

  Xu et al. (2026) introduce functionalized EGCG nanoparticles (BENPs) as radiosensitizers that significantly augment the antitumor effect of ultra-high dose rate FLASH radiotherapy. Their work demonstrates increased DNA damage, robust immune activation, and improved tumor control, providing mechanistic insights and translational value for future clinical FLASH-RT protocols.

• Fumagillin: Applied Protocols for MetAP-2 Inhibition Researc

  2026-05-19

  Fumagillin’s dual role as a methionine aminopeptidase-2 inhibitor unlocks precision in angiogenesis and antiparasitic workflows. This article distills bench-validated protocol details, troubleshooting wisdom, and cross-domain insights to empower researchers leveraging APExBIO’s Fumagillin in advanced cancer and aquatic disease models.

• Cytoskeleton-Dependent Autophagy Triggered by Mechanical Str

  2026-05-18

  This study demonstrates that cytoskeletal microfilaments are essential mediators of autophagy induced by mechanical compression in human cells, with microtubules playing a secondary role. The findings clarify mechanotransduction pathways and inform experimental strategies for probing redox and stress-response crosstalk in cell biology.

• ROS-Driven Metabolic Rewiring in BRAF Inhibitor-Treated Mela

  2026-05-18

  Cesi et al. (2017) reveal that BRAF inhibitor treatment in melanoma cells triggers reactive oxygen species (ROS) production, which activates pyruvate dehydrogenase kinases (PDKs) and rewires central metabolism. This mechanistic insight highlights metabolic vulnerabilities in drug-resistant melanoma and supports targeting PDKs as a therapeutic strategy.

• D-N-Acetylgalactosamine: Protocols for Brain Glycoprotein An

  2026-05-17

  D-N-Acetylgalactosamine is used to reliably investigate glycoprotein constituents and glycosylation pathways in brain tissue. Its high purity and water solubility make it suitable for workflows requiring precise, rapid preparation, but it is unsuitable for ethanol-based protocols or long-term storage of solutions. Proper handling and adherence to technical parameters are essential for reliable data.

• Peptidisc-Driven Nanobody Clustering: Advances in Polybody E

  2026-05-16

  Chen and Duong van Hoa introduce a peptidisc-assisted approach for clustering nanobodies into multimeric and multispecific assemblies, termed polybodies. This innovative strategy leverages hydrophobic transmembrane segments stabilized by peptidiscs, enhancing protein stability and avidity while expanding the toolkit for protein engineering and detection.

451 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page